Search results
Novo (NVO) Posts Positive Data From Diabetes Study on CagriSema
Zacks via Yahoo Finance· 2 years agoNovo Nordisk A/S NVO announced that it has completed the phase II study evaluating CagriSema, a...
Novo Nordisk's Subcutaneous Semaglutide Shows Positive Action In Type 2 Diabetes
Benzinga via Yahoo Finance· 2 years agoNovo Nordisk A/S (NYSE: NVO) has announced headline results from a Phase 2 trial of CagriSema, a...
Forget Tesla: I Think This Stock Should Replace It in the "Magnificent Seven"
Motley Fool via Yahoo Finance· 3 months agoStruggling basketball players sometimes get replaced in their team's starting lineup. So do athletes...
A Complete Guide to Type 1 Diabetes Medications
Verywell Health via Yahoo News· 1 week agoInsulin is the most common medication used to treat type 1 diabetes. Learn more about insulin and other medications often prescribed to help manage this...
Here's Why You Should Add Novo (NVO) Stock to Your Portfolio
Zacks via Yahoo Finance· 1 year agoNovo (NVO), a top-ranked stock at present, enjoys a strong foothold in the Diabetes Care market with...
Experimental drugs aim to surpass weight-loss stars like Ozempic and Wegovy
CNN via Yahoo News· 1 year agoThe new crop of drugs on the market for type 2 diabetes and obesity, including popular medications...